Stereotaxis , Inc.

Industry:	Medical Devices & Equipment
Ranking:	Russell 3000
Revenues:	$39.3 Million
Employees:	180

Description

Stereotaxis, Inc. designs, manufactures and markets cardiology instrument control system for use in a hospital’s interventional surgical suite, or interventional lab, to enhance the treatment of arrhythmias and coronary artery disease. The NIOBE System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. In addition to the NIOBE System and its components, the Company also has developed the Odyssey information management system, which consolidates the multiple sources of diagnostic and imaging information found in the interventional lab into a large-screen user interface with single mouse control, which can be connected via a private network line to other interventional labs or to a remote clinical call center.
(Source: 10-K)

Products & Services

medical devices, cardiology instrument control system

Find More Jobs

Job Openings

Network Engineer St. Louis , MO

Director, Odyssey Sales-NE Boston , MA

Director, Clinical Adoption-West San Francisco , CA

Instructional Designer St. Louis , MO

Account Manager Houston , TX

View More Statistics

Site Statistics

Monthly Unique Visitors:	518
Site Rank:	1,943,065
Trust Rating:	Neutral
Stats by

News Archive

Stereotaxis Showcases Interventional Value of Magnetic Navigation at TCT 2009. PR Newswire; 9/24/2009 ...24 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. is showcasing the value of its...symposium in San Francisco this week. Stereotaxis pioneered remote magnetic navigation...the cath lab as well as the EP lab, Stereotaxis' computer-controlled devices, integrated... ...more

Stereotaxis Names Daniel Johnston as Chief Financial Officer. PR Newswire; 8/6/2009 ...6 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. today announced that its Board...November 15, 2009. He will join Stereotaxis in September, 2009 and replace James M. Stolze (66), Stereotaxis' current Chief Financial Officer... ...more

Stereotaxis Announces Pricing of $26 Million Common Stock Offering. PR Newswire; 10/9/2009 ...Oct. 9 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. announced today that it had...to the public of $4.00 per share. Stereotaxis has granted the underwriters of the...in the offering are being offered by Stereotaxis. Stereotaxis expects the offering to... ...more